Read news on aumolertinib with our app.
Read more in the app
Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study - EurekAlert!
Pharmacokinetics comparison of aumolertinib - EurekAlert
